IRIS UniCatt

Iorio, Raffaele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.869
AS - Asia 4.216
EU - Europa 4.180
SA - Sud America 914
AF - Africa 114
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.673
SG - Singapore 1.769
DE - Germania 1.514
CN - Cina 1.070
BR - Brasile 719
SE - Svezia 591
IT - Italia 521
VN - Vietnam 393
FR - Francia 356
UA - Ucraina 288
GB - Regno Unito 222
IN - India 203
BD - Bangladesh 168
IE - Irlanda 166
FI - Finlandia 151
ID - Indonesia 116
CA - Canada 103
RU - Federazione Russa 94
JP - Giappone 92
HK - Hong Kong 83
AR - Argentina 66
TR - Turchia 62
MX - Messico 57
PL - Polonia 56
IQ - Iraq 47
NL - Olanda 37
BE - Belgio 34
EC - Ecuador 34
KR - Corea 32
CI - Costa d'Avorio 31
ES - Italia 29
AT - Austria 28
CO - Colombia 25
ZA - Sudafrica 25
PK - Pakistan 24
SA - Arabia Saudita 23
UZ - Uzbekistan 19
PY - Paraguay 18
VE - Venezuela 18
CH - Svizzera 16
LT - Lituania 15
AU - Australia 14
CL - Cile 14
IR - Iran 14
MA - Marocco 14
JO - Giordania 11
KE - Kenya 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
EG - Egitto 9
OM - Oman 8
CR - Costa Rica 7
IL - Israele 7
MY - Malesia 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
PT - Portogallo 7
TN - Tunisia 7
UY - Uruguay 7
DZ - Algeria 6
BO - Bolivia 5
BY - Bielorussia 5
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
LV - Lettonia 5
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
JM - Giamaica 4
MD - Moldavia 4
NI - Nicaragua 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
PS - Palestinian Territory 3
SI - Slovenia 3
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
LB - Libano 2
LY - Libia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
Totale 15.292
Salva come PNG Salva come JPEG
Città #
Singapore 938
Ashburn 724
Chandler 684
San Jose 537
New York 229
Beijing 214
Jacksonville 209
Ann Arbor 180
Dublin 157
Los Angeles 144
Ho Chi Minh City 142
San Mateo 131
Hefei 130
Lauterbourg 106
Nanjing 105
Nürnberg 100
Hanoi 97
Jakarta 96
Chicago 93
Rome 92
Woodbridge 86
Dearborn 85
Houston 79
Tokyo 78
Frankfurt am Main 76
Munich 75
Hong Kong 74
São Paulo 68
Wilmington 68
Dallas 62
Milan 62
Boston 59
Buffalo 59
Marseille 51
Bremen 49
Cattolica 48
Moscow 48
Santa Clara 48
Helsinki 47
Orem 47
North Bergen 43
Lawrence 39
Princeton 39
Boardman 38
Redmond 38
Redwood City 36
Seattle 36
Kent 35
Nanchang 35
Warsaw 35
Brussels 34
Izmir 34
London 32
Turku 32
Abidjan 31
Seoul 31
Düsseldorf 30
Norwalk 30
The Dalles 30
Atlanta 29
Council Bluffs 29
Montreal 28
Hangzhou 27
Nuremberg 27
Shanghai 25
Chennai 24
Brooklyn 22
Denver 21
Mexico City 21
Paris 21
Phoenix 21
Detroit 20
Mountain View 20
Ottawa 20
Pune 20
Shenyang 20
Amsterdam 19
St Louis 19
Poplar 18
Rio de Janeiro 18
Stockholm 18
Tianjin 18
Belo Horizonte 17
Johannesburg 17
Tashkent 17
University Park 17
Baghdad 16
Manchester 16
Monza 16
San Francisco 16
Trieste 16
Da Nang 15
Fairfield 15
Salvador 15
Changsha 14
Leawood 14
Lappeenranta 13
Dhaka 12
Hebei 12
Quito 12
Totale 7.810
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 264
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 246
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 240
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 239
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 223
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 212
Acute necrotizing Encephalopathy during novel influenza A (H1N!) virus infection 209
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 198
null 198
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 196
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 194
Multiple Sclerosis attacks triggered by hyperprolactinemia 194
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 191
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 191
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 186
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 184
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 182
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 180
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 177
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 174
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 173
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 170
Complement inhibitor therapy as a steroid-sparing strategy in generalized myasthenia gravis 169
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 169
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis 168
Type 1 immune response in progressive Multiple Sclerosis 167
Copper deficiency myelopathy: A report of two cases 167
A Case of Hemiabdominal Myoclonus 166
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 165
Myasthenia gravis with antibodies to MuSK: an update 164
Replay to Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E. 163
3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies 162
A b3 type-thymoma in a 7-year-old child with myasthenia gravis 161
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach 161
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 155
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 155
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 155
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 152
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 152
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology 149
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 148
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 146
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 146
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients 143
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II) 142
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 142
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 140
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 138
Breastfeeding and multiple sclerosis 137
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review 137
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience 136
Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis 135
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 134
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 133
A Case of Hemiabdominal Myoclonus 133
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 132
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies 131
SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) 131
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 131
Glioblastoma in multiple sclerosis: a case report 130
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 130
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 128
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology 125
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 124
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 122
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor 120
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis 120
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 118
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 117
Multiple sclerosis attacks triggered by hyperprolactinemia 116
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 115
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 113
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 112
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 112
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 110
Focal hyperhidrosis in tumefactive Multiple Sclerosis 110
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 110
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 109
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 107
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study 105
Controversies in Ocular Myasthenia Gravis 104
Nine syndrome 103
Assessment of neurological manifestations in hospitalized patients with COVID-19 102
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 99
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4 99
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I) 98
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 96
Isolated Memory Loss in Anti-NMDAR Encephalitis 95
Movement disorders phenomenology in focal motor seizures 91
Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes 90
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience 89
Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility 88
Epilepsia Partialis Continua as a manifestation of aquaporin-4 autoimmunity 85
Thymoma resection and myasthenia gravis: what is the neurological outcome in patients older than 65 years? 82
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 81
Paraneoplastic neurological syndromes 79
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 75
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 75
Demographic and clinical features of neuromyelitis optica: A review 74
Totale 14.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022802 75 48 24 74 41 18 22 101 36 62 123 178
2022/20231.856 200 248 148 307 98 225 98 159 241 52 52 28
2023/20241.034 36 247 36 113 26 188 69 44 18 29 112 116
2024/20252.184 36 81 146 80 115 58 96 98 347 200 461 466
2025/20266.187 939 179 368 862 1.050 251 877 288 378 485 229 281
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 15.536